Improved injection site reactions after switching from adalimumab reference to adalimumab biosimilar LBAL for ulcerative colitis: A case report
PMID: 39496006
Source: Medicine (Baltimore)
Publication date:
2025-07-24
Year:
2024
Abstract
NULL